NIH Official Discusses Need To Issue Exclusive License To Drug Company For Zika Vaccine Development With U.S. House, Senate Staff
CQ HealthBeat: NIH Tries to Ease Concerns About Zika Vaccine Deal
“The federal government is considering granting a pharmaceutical company an exclusive license to further develop a taxpayer-funded vaccine for the Zika virus, just weeks after a similar arrangement was scuttled following blowback from health groups and lawmakers. … In a pair of conference calls with House and Senate staff members, [NIAID Director Anthony] Fauci made a case for why the government needs industry partners to get a Zika vaccine to market…” (Siddons, 10/16).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.